Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 60+
Code: NCT06296368
Recruiting
Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 6+
Code: NCT07634653
Recruiting
Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma
for
Large B-cell Lymphoma, Relapse
Location: Miami FL
Sponsor: University of Miami
Sex: All
Age: 18+
Code: NCT06919939
Phase2, Recruiting
Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)
for
Marginal Zone Lymphoma,
Location: Miami FL
Sponsor: Izidore Lossos, MD
Sex: All
Age: 18+
Code: NCT06796998
Phase2, Recruiting
Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
for
T-cell-prolymphocytic Leukemia,
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT06810778
Phase1, Phase2, Recruiting
Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma
for
Relapsed CLL, Refractory CLL, Refractory Lymphoma
Location: Cleveland OH
Sponsor: Paolo Caimi, MD
Sex: All
Age: 18+
Code: NCT06916767
Phase1, Recruiting
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
for
Lymphoma
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT02974647
Phase2, Recruiting
Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL)
for
Relapsed Non Hodgkin Lymphoma, Relapsed Adult ALL,
Location: Edmonton
Sponsor: University of Alberta
Sex: All
Age: 2 - 70
Code: NCT03938987
Phase1, Phase2, Recruiting
IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL
for
Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18+
Code: NCT06768905
Phase1, Phase2, Recruiting
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 18 - 70+
Code: NCT01137643
Recruiting
Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
for
Mantle Cell Lymphoma, Follicular Lymphoma,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center